Dermapharm Holding Operating Margin vs. Return On Asset

DMP Stock   37.80  0.10  0.26%   
Considering the key profitability indicators obtained from Dermapharm Holding's historical financial statements, Dermapharm Holding SE may not be well positioned to generate adequate gross income at the moment. It has a very high risk of underperforming in January. Profitability indicators assess Dermapharm Holding's ability to earn profits and add value for shareholders.
For Dermapharm Holding profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Dermapharm Holding to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Dermapharm Holding SE utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Dermapharm Holding's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Dermapharm Holding SE over time as well as its relative position and ranking within its peers.
  
Check out Investing Opportunities.
Please note, there is a significant difference between Dermapharm Holding's value and its price as these two are different measures arrived at by different means. Investors typically determine if Dermapharm Holding is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Dermapharm Holding's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Dermapharm Holding Return On Asset vs. Operating Margin Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining Dermapharm Holding's current stock value. Our valuation model uses many indicators to compare Dermapharm Holding value to that of its competitors to determine the firm's financial worth.
Dermapharm Holding SE is rated # 2 in operating margin category among its peers. It also is rated # 2 in return on asset category among its peers reporting about  0.46  of Return On Asset per Operating Margin. The ratio of Operating Margin to Return On Asset for Dermapharm Holding SE is roughly  2.18 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Dermapharm Holding's earnings, one of the primary drivers of an investment's value.

Dermapharm Return On Asset vs. Operating Margin

Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.

Dermapharm Holding

Operating Margin

 = 

Operating Income

Revenue

X

100

 = 
0.26 %
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.

Dermapharm Holding

Return On Asset

 = 

Net Income

Total Assets

 = 
0.12
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.

Dermapharm Return On Asset Comparison

Dermapharm Holding is one of the top stocks in return on asset category among its peers.

Dermapharm Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on Dermapharm Holding. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Dermapharm Holding position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Dermapharm Holding's important profitability drivers and their relationship over time.

Use Dermapharm Holding in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Dermapharm Holding position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Dermapharm Holding will appreciate offsetting losses from the drop in the long position's value.

Dermapharm Holding Pair Trading

Dermapharm Holding SE Pair Trading Analysis

The ability to find closely correlated positions to Dermapharm Holding could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Dermapharm Holding when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Dermapharm Holding - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Dermapharm Holding SE to buy it.
The correlation of Dermapharm Holding is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Dermapharm Holding moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Dermapharm Holding moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Dermapharm Holding can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your Dermapharm Holding position

In addition to having Dermapharm Holding in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Developed Markets Basket ETFs Thematic Idea Now

Developed Markets Basket ETFs
Developed Markets Basket ETFs Theme
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Developed Markets Basket ETFs theme has 24 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Developed Markets Basket ETFs Theme or any other thematic opportunities.
View All  Next Launch

Additional Tools for Dermapharm Stock Analysis

When running Dermapharm Holding's price analysis, check to measure Dermapharm Holding's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Dermapharm Holding is operating at the current time. Most of Dermapharm Holding's value examination focuses on studying past and present price action to predict the probability of Dermapharm Holding's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Dermapharm Holding's price. Additionally, you may evaluate how the addition of Dermapharm Holding to your portfolios can decrease your overall portfolio volatility.